Clinical Trial Update: Bevacizumab Injection for Recurrent Pterygium

View source ↗

Summary

This document reports the completion of a clinical trial testing bevacizumab injections for recurrent pterygium.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pterygium

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana | Conditions: Recurrent Pterygium | Status: COMPLETED